TAIWAN · TWSE / TPEx
DuoGenic
通用幹細胞* · 7607 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$8.251 month -20.7% · 1 year -46.3%
Directors and supervisors hold9,752,44926.6% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold12,855,17135.1% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 蘇鴻麟 | Chairman · President · Major shareholder (10%+) | 8,344,828 | 9,144,828 | 24.95% | — | 1,431,567 |
| 張鑫隆 | Director | 230,897 | 330,897 | 0.90% | — | — |
| 蔡吳鑫 | Director · President | 260,724 | 260,724 | 0.71% | — | 143,634 |
| 黃國賢 | Director | 16,000 | 16,000 | 0.04% | — | — |
| 廖大穎 | Independent director | — | 0 | — | — | — |
| 陳威宏 | Independent director | — | 0 | — | — | — |
| 林敬雲 | Independent director | — | 0 | — | — | — |
| 生寶國際生技股份有限公司 | Major shareholder (10%+) | — | 3,710,343 | 10.12% | — | — |
| ?凱騫 | Other | — | 0 | — | — | — |